Skip to content

Study · Animal study (in vivo) · rat · 2012

4 results

NAD(+) administration significantly attenuates synchrotron radiation X-ray-induced DNA damage and structural alterations of rodent testes.

Sheng C, Chen H, Wang B, Liu T, Hong Y, Shao J, He X, Ma Y, Nie H, Liu N, Xia W, Ying W

International journal of physiology, pathophysiology and pharmacology1 Mar 2012Cited by 20 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study4

4 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Mechanism

    In rat testes, 125 mg/kg NAD significantly decreased double-strand DNA damage induced by 40 Gy SR X-ray.

    In plain wordsIn rats, 125 mg/kg NAD reduced testicular DNA damage induced by 40 Gy SR X-ray.

    Outcome
    DecreaseDouble-strand DNA damage at 125 mg/kg
    Study

    ratn: not reported in source

    Synchrotron radiation X-ray-exposed testes
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health
    Studied dose
    125 mg/kg · intraperitonealAs given in this study (rat).

    Source sentences

    Summary
    We found that 40 Gy of SR X-ray induced a massive increase in double-strand DNA damage, as assessed by both immunostaining and Western blot of phosphorylated H2AX levels, which was significantly decreased by intraperitoneally (i.p.) administered NAD(+) at doses of 125 and 625 mg/kg.
    2 context sentences
    Summary · context
    In this study we used the testes of rats as a model to characterize SR X-ray-induced tissue damage, and to test our hypothesis that NAD(+) administration can prevent SR X-ray-induced injury of the testes.
    Summary · context
    We first determined the effects of SR X-ray at the doses of 0, 0.5, 1.3, 4 and 40 Gy on the biochemical and structural properties of the testes one day after SR X-ray exposures.
  2. 02AnimalAnimal study (in vivo)Mechanism

    In rat testes, 625 mg/kg NAD significantly decreased double-strand DNA damage induced by 40 Gy SR X-ray.

    In plain wordsIn rats, 625 mg/kg NAD reduced testicular DNA damage induced by 40 Gy SR X-ray.

    Outcome
    DecreaseDouble-strand DNA damage at 625 mg/kg
    Study

    ratn: not reported in source

    Synchrotron radiation X-ray-exposed testes
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health
    Studied dose
    625 mg/kg · intraperitonealAs given in this study (rat).

    Source sentences

    Summary
    We found that 40 Gy of SR X-ray induced a massive increase in double-strand DNA damage, as assessed by both immunostaining and Western blot of phosphorylated H2AX levels, which was significantly decreased by intraperitoneally (i.p.) administered NAD(+) at doses of 125 and 625 mg/kg.
    2 context sentences
    Summary · context
    In this study we used the testes of rats as a model to characterize SR X-ray-induced tissue damage, and to test our hypothesis that NAD(+) administration can prevent SR X-ray-induced injury of the testes.
    Summary · context
    We first determined the effects of SR X-ray at the doses of 0, 0.5, 1.3, 4 and 40 Gy on the biochemical and structural properties of the testes one day after SR X-ray exposures.
  3. 03AnimalAnimal study (in vivo)Efficacy outcome

    In rat testes, NAD ameliorated the SR X-ray-induced increase in abnormal cell nuclei one day after exposure.

    In plain wordsIn rats, NAD reduced the increase in abnormal testicular cell nuclei after SR X-ray exposure.

    Outcome
    DecreaseAbnormal cell nuclei
    Study

    ratn: not reported in source

    Synchrotron radiation X-ray-exposed testes
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health
    Studied dose
    Dose not stated · intraperitonealAs given in this study (rat).

    Source sentences

    Summary
    Forty Gy of SR X-ray can also induce marked increases in abnormal cell nuclei as well as significant decreases in the cell layers of the seminiferous tubules one day after SR X-ray exposures, which were also ameliorated by the NAD(+) administration.
    2 context sentences
    Summary · context
    In this study we used the testes of rats as a model to characterize SR X-ray-induced tissue damage, and to test our hypothesis that NAD(+) administration can prevent SR X-ray-induced injury of the testes.
    Summary · context
    We first determined the effects of SR X-ray at the doses of 0, 0.5, 1.3, 4 and 40 Gy on the biochemical and structural properties of the testes one day after SR X-ray exposures.
  4. 04AnimalAnimal study (in vivo)Efficacy outcome

    In rat testes, NAD ameliorated the SR X-ray-induced decrease in seminiferous tubule cell layers one day after exposure.

    In plain wordsIn rats, NAD reduced the loss of seminiferous tubule cell layers after SR X-ray exposure.

    Outcome
    IncreaseSeminiferous tubule cell layers
    Study

    ratn: not reported in source

    Synchrotron radiation X-ray-exposed testes
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health
    Studied dose
    Dose not stated · intraperitonealAs given in this study (rat).

    Source sentences

    Summary
    Forty Gy of SR X-ray can also induce marked increases in abnormal cell nuclei as well as significant decreases in the cell layers of the seminiferous tubules one day after SR X-ray exposures, which were also ameliorated by the NAD(+) administration.
    2 context sentences
    Summary · context
    In this study we used the testes of rats as a model to characterize SR X-ray-induced tissue damage, and to test our hypothesis that NAD(+) administration can prevent SR X-ray-induced injury of the testes.
    Summary · context
    We first determined the effects of SR X-ray at the doses of 0, 0.5, 1.3, 4 and 40 Gy on the biochemical and structural properties of the testes one day after SR X-ray exposures.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.